What is the recommended levofloxacin dosage for an adult with Ochrobactrum anthropi infection, including renal‑function dose adjustments?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Levofloxacin Dosing for Ochrobactrum anthropi Infection

For adult patients with normal renal function (CrCl ≥50 mL/min), administer levofloxacin 500–750 mg orally or intravenously once daily for 7–14 days, with dose adjustments required for renal impairment. 1, 2

Standard Dosing in Adults with Normal Renal Function

  • 500 mg once daily is the standard dose for most O. anthropi infections, given the organism's high susceptibility to levofloxacin (100% susceptibility in clinical series). 2
  • 750 mg once daily may be considered for severe infections or sepsis to optimize peak concentration-dependent killing, particularly in critically ill patients. 3, 4
  • Duration should be 7–14 days depending on infection severity and clinical response; bloodstream infections typically require 10–14 days. 2
  • Levofloxacin can be administered without regard to food, and both oral and intravenous formulations achieve equivalent bioavailability (approaching 100%). 1, 5

Renal Dose Adjustments

Moderate Renal Impairment (CrCl 20–49 mL/min)

  • Loading dose: 500 mg, followed by 250 mg once daily. 6, 1
  • This regimen prevents drug accumulation while maintaining therapeutic concentrations. 6

Severe Renal Impairment (CrCl 10–19 mL/min)

  • Loading dose: 500 mg, followed by 250 mg every 48 hours. 6, 1
  • The extended interval compensates for the markedly prolonged elimination half-life (up to 34 hours in end-stage renal disease). 7

End-Stage Renal Disease on Hemodialysis

  • Loading dose: 500 mg immediately after the first dialysis session. 6, 7
  • Maintenance: 250 mg every 48 hours, administered immediately after each dialysis session (for thrice-weekly dialysis). 6, 7
  • Never administer before or during hemodialysis, as approximately 24% of the drug is removed during each session, leading to subtherapeutic levels. 6, 7
  • Supplemental post-dialysis dosing is not required beyond the scheduled maintenance dose. 1

Peritoneal Dialysis

  • Use the hemodialysis regimen (500 mg loading, then 250 mg every 48 hours) and adjust based on clinical response and therapeutic drug monitoring if available. 6
  • Evidence for peritoneal dialysis dosing is limited, requiring careful clinical monitoring. 6

Pharmacodynamic Considerations for O. anthropi

  • O. anthropi demonstrates 100% susceptibility to levofloxacin in published case series, with MIC values typically ≤1 mg/L. 2
  • Target pharmacodynamic parameters for optimal bactericidal activity: AUC₂₄/MIC ≥125 and Cmax/MIC ≥10 for Gram-negative organisms. 6
  • The standard 500 mg daily dose achieves peak concentrations of 5.2–7.5 mg/L, providing Cmax/MIC ratios >5 for organisms with MIC ≤1 mg/L. 5, 8
  • For critically ill patients, higher doses (750 mg daily) optimize concentration-dependent killing and account for increased volume of distribution from fluid resuscitation. 3, 4, 8

Clinical Context and Treatment Duration

  • O. anthropi bloodstream infections typically occur in patients with indwelling catheters or foreign bodies, and catheter removal is essential for recurrent infections. 2
  • Most infections are hospital-acquired (64% in one series) and may present with fever and altered mental status. 2
  • The organism is widely resistant to penicillins and cephalosporins but highly susceptible to fluoroquinolones (levofloxacin, ciprofloxacin) and carbapenems (imipenem). 2
  • Monotherapy with levofloxacin is appropriate for most O. anthropi infections given its excellent susceptibility profile; combination therapy is not routinely required. 2

Important Caveats

  • Drug interactions: Administer levofloxacin at least 2 hours before or after antacids containing magnesium/aluminum, sucralfate, iron supplements, or multivitamins with zinc to avoid significantly decreased absorption. 1, 5
  • Therapeutic drug monitoring should be considered in patients with end-stage renal disease to ensure adequate exposure while preventing accumulation. 6
  • Adequate hydration should be maintained to prevent crystalluria, though this is rare with levofloxacin. 1
  • For patients with severe renal dysfunction requiring dialysis, consultation with a nephrologist is advised for complex dosing scenarios. 9
  • The loading dose (500 mg) is independent of renal function and should always be given to rapidly achieve therapeutic concentrations, particularly in severe infections. 6, 7

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.